Skip to main content
. 2021 Nov 12;11:796839. doi: 10.3389/fonc.2021.796839

Table 1.

FBI-1 expression and clinical outcome of Sorafenib treatment.

FBI-1 mRNA expression p
High (n = 26) Low (n = 26)
TTP 9.0 14.0 0.003
7.1-11.0 (M) 10.1-13.3 (M)
OS 10.0 15.0 0.001
7.2–12.8 (M) 12.1–17.6 (M)

TTP, time to progress; OS, overall survival; M, months.